BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: van Turenhout ST, van Rossum LG, Oort FA, Laheij RJ, van Rijn AF, Terhaar sive Droste JS, Fockens P, van der Hulst RW, Bouman AA, Jansen JB, Meijer GA, Dekker E, Mulder CJ. Similar fecal immunochemical test results in screening and referral colorectal cancer. World J Gastroenterol 2012; 18(38): 5397-5403 [PMID: 23082056 DOI: 10.3748/wjg.v18.i38.5397]
URL: https://www.wjgnet.com/1007-9327/full/v18/i38/5397.htm
Number Citing Articles
1
Bianca Rosa Viana Freitas, Cristiane Kibune Nagasako, Celia Regina Pavan, Sônia Letícia Silva Lorena, Fabio Guerrazzi, Cláudio Saddy Rodrigues Coy, Maria de Lourdes S. Ayrizono, Maria Aparecida Mesquita. Immunochemical Fecal Occult Blood Test for Detection of Advanced Colonic Adenomas and Colorectal Cancer: Comparison with Colonoscopy ResultsGastroenterology Research and Practice 2013; 2013: 1 doi: 10.1155/2013/384561
2
Tobias Niedermaier, Yesilda Balavarca, Hermann Brenner. Stage-Specific Sensitivity of Fecal Immunochemical Tests for Detecting Colorectal Cancer: Systematic Review and Meta-AnalysisAmerican Journal of Gastroenterology 2020; 115(1): 56 doi: 10.14309/ajg.0000000000000465
3
Tobias Niedermaier, Kaja Tikk, Anton Gies, Stefanie Bieck, Hermann Brenner. Sensitivity of Fecal Immunochemical Test for Colorectal Cancer Detection Differs According to Stage and LocationClinical Gastroenterology and Hepatology 2020; 18(13): 2920 doi: 10.1016/j.cgh.2020.01.025
4
Marie Westwood, Isaac Corro Ramos, Shona Lang, Marianne Luyendijk, Remziye Zaim, Lisa Stirk, Maiwenn Al, Nigel Armstrong, Jos Kleijnen. Faecal immunochemical tests to triage patients with lower abdominal symptoms for suspected colorectal cancer referrals in primary care: a systematic review and cost-effectiveness analysisHealth Technology Assessment 2017; 21(33): 1 doi: 10.3310/hta21330
5
Seiji Kimura, Shinichiro Yamagishi, Shinsaku Fukuda. Clinicopathological Characteristics of Colorectal Adenomas and Cancers Detected by FIT-positive ColonoscopyNippon Daicho Komonbyo Gakkai Zasshi 2020; 74(1): 6 doi: 10.3862/jcoloproctology.74.6
6
Sietze T van Turenhout, Frank A Oort, René WM van der Hulst, Arjen P Visscher, Jochim S Terhaar sive Droste, Pieter Scholten, Anneke A Bouman, Gerrit A Meijer, Chris JJ Mulder, Leo GM van Rossum, Veerle MH Coupé. Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?BMC Gastroenterology 2014; 14(1) doi: 10.1186/s12876-014-0217-7
7
Marie Westwood, Shona Lang, Nigel Armstrong, Sietze van Turenhout, Joaquín Cubiella, Lisa Stirk, Isaac Corro Ramos, Marianne Luyendijk, Remziye Zaim, Jos Kleijnen, Callum G. Fraser. Faecal immunochemical tests (FIT) can help to rule out colorectal cancer in patients presenting in primary care with lower abdominal symptoms: a systematic review conducted to inform new NICE DG30 diagnostic guidanceBMC Medicine 2017; 15(1) doi: 10.1186/s12916-017-0944-z
8
Eunyoung Lee, Yangsoon Lee. Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?Annals of Laboratory Medicine 2018; 38(1): 51 doi: 10.3343/alm.2018.38.1.51
9
Kevin Selby, Christopher D. Jensen, Jeffrey K. Lee, Chyke A. Doubeni, Joanne E. Schottinger, Wei K. Zhao, Jessica Chubak, Ethan Halm, Nirupa R. Ghai, Richard Contreras, Celette Skinner, Aruna Kamineni, Theodore R. Levin, Douglas A. Corley. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer DetectionAnnals of Internal Medicine 2018; 169(7): 439 doi: 10.7326/M18-0244
10
Carolyn M Rutter, Pedro Nascimento de Lima, Christopher E Maerzluft, Folasade P May, Caitlin C Murphy. Black-White disparities in colorectal cancer outcomes: a simulation study of screening benefitJNCI Monographs 2023; 2023(62): 196 doi: 10.1093/jncimonographs/lgad019